Skip to content

Laser Speckle Imaging of blood flow in the microcirculation of the cerebral cortex

Laser Speckle Imaging of blood flow in the microcirculation of the cerebral cortex - Laser Speckle Imaging of cerbral cortex

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36491
Enrollment
40
Registered
2011-02-11
Start date
2013-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

function of the microcirculation in the cerebral cortex

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients that will undergo an awake craniotomy will be eligible for protocol A. They have to be at least 18 years old and there has to be informed consent. All patients that will undergo a craniotomy under anaesthesia are eligible for protocol B. They have to be at least 18 years old and there has to be informed consent.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
The aim of the study is two-sided. First we propose to investigate and further develop the use of LSI to asses blood flow changes coupled to neuronal activities and to find out whether this approach can be used during tumor dissection. Secondly we aim to investigate the effects of several therapeutic standard interventions (infusion of mannitol, artificial elevation of mean arterial pressure and placement of surgical devices), which are expected to influence CBF, and are routinely used during neurosurgical procedures on microcirculatory flow in the brain, with and without the use of Transcranial Doppler Ultrasound to compare blood flow velocity in the microvasculature with the larger cerebral arteries.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)